OIRA Conclusion of EO 12866 Regulatory Review

RIN: 0910-AH89         View EO 12866 Meetings Received Date: 10/05/2018 
Title: Format and Content of Reports Intended to Demonstrate Substantial Equivalence 
Agency/Subagency: HHS / FDA   Stage: Proposed Rule 
Concluded Action: Consistent with Change  Concluded Date: 03/18/2019 
Legal Deadline: None  Economically Significant: No 
Publication Date: 04/02/2019  Unfunded Mandates: No 
Major: No  Related To Homeland Security: No 
Regulatory Flexibility Analysis Required: No  Small Entities Affected:  
Federalism Implications: No  Affordable Care Act [Pub. L. 111-148 & 111-152]: No
International Impacts: No Dodd-Frank Wall Street Reform and Consumer Protection Act, [Pub. L. 111-203]: No
Pandemic Response: Uncollected